Although the sensitivity and specificity of RNF180 and SFRP2 for diagnosing GC alone were low, their combination yielded better results, with a sensitivity of 82.4 % and a specificity of 42.86 % [46]. The gene discussed is SFRP2; the disease is gastric cancer.